Low-dose rituximab is poorly effective in patients with primary membranous nephropathy-Reference-Cited by-同舟云学术

Low-dose rituximab is poorly effective in patients with primary membranous nephropathy

Published:2016-07-06 Issue: Volume: Page:gfw251
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrol. Dial. Transplant.

Author:

Moroni Gabriella,Depetri Federica,Del Vecchio Lucia,Gallelli Beniamina,Raffiotta Francesca,Giglio Elisa,Brunini Francesca,D'Amico Marco,Longhi Selena,Radice Antonella,Messa Piergiorgio,Sinico Renato Alberto

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/doi/10.1093/ndt/gfw251/10860194/gfw251.pdf

Reference28 articles.

1. M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous Nephropathy

2. Coexistence of Different Circulating Anti-Podocyte Antibodies in Membranous Nephropathy

3. Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy

4. Spontaneous Remission of Nephrotic Syndrome in Idiopathic Membranous Nephropathy

5. A review of therapeutic studies of idiopathic membranous glomerulopathy

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel approaches to primary membranous nephropathy: Beyond the KDIGO guidelines;European Journal of Pharmacology;2024-11

2. Obinutuzumab as Initial or Second-Line Therapy in Patients With Primary Membranous Nephropathy;Kidney International Reports;2024-08

3. Differences in risk of serious infections between patients with secondary versus primary nephropathy following rituximab treatment: a retrospective cohort study;Frontiers in Immunology;2024-06-11

4. Ten tips on immunosuppression in primary membranous nephropathy;Clinical Kidney Journal;2024-04-29

5. Dosing optimization of rituximab for primary membranous nephropathy by population pharmacokinetic and pharmacodynamic study;Frontiers in Pharmacology;2024-03-26